TSHR and hyperthyroidism: Of note, several ECL1 mutations that alter TSHR constitutive activity have been identified in patients with hypothyroidism (TSHR loss-of-function) [48] or hyperthyroidism (gain-of-function) [49] emphasizing the importance of ECL1 in in vivo settings.